A delegation from the China Association of In Vitro Diagnostics (CAIVD), the China Professional Community of Experimental Medicine (CPCEM), and CACLP visited Incheon for a four-day industry and academic exchange program.
Following its announcement to return to Xiamen in 2026, CACLP has received overwhelming enthusiasm from exhibitors worldwide. As of October 2025, more than 1,000 companies have confirmed their participation for next year’s event, reaffirming CACLP’s role as the world‘s largest IVD event and an important annual gathering of the global diagnostic community.
The 3rd IVD Key Upstream Raw Material Forum was successfully held on August 22nd in Nanchang, Jiangxi.
The 2nd China IVD Distribution Enterprise Forum was successfully held in Nanchang, Jiangxi on August 22nd.
The 17th CACLP EXPO successfully held in Nanchang Greenland International Expo Center from Aug. 21st to 23rd.
Enlightening Lab Med·The 3rd IVD Youth Entrepreneur Forum was successfully organized by CAIVD on August 21st in Nanchang, Jiangxi.
The 5th China Experimental Medicine Conference/Wiley Conference on In Vitro Diagnostics (CEMC) was successfully opened at 15:30 on August 21st in Nanchang.
The 7th CIIDC will be held at Primus Hotel Nanchang International Expo City in August 20th, 2020.
CACLP is coming!!!
The American Red Cross has begun testing all blood, platelet and plasma donations for COVID-19 antibodies.
The 7th CIIDC will be held at Primus Hotel Nanchang International Expo City in August 20th, 2020.
Enlightening Lab Med?The 3rd IVD Youth Entrepreneur Forum will be held on 21st August in Nanchang, China.
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.